
Management Change28 Jul 2026, 10:05 am
Torrent Pharma Appoints Shanti Ekambaram as Independent Director
AI Summary
Torrent Pharmaceuticals Ltd. has announced the appointment of Shanti Ekambaram as an Additional Independent Director to its Board of Directors. This appointment, effective from July 30, 2026, is for a term of three consecutive years, subject to shareholder approval. Ms. Ekambaram brings extensive experience, with 39 years in financial services, including a significant 35-year tenure at Kotak Mahindra Bank, where she held the position of Deputy Managing Director and Whole-time Director. Her expertise spans banking, capital markets, and governance. She is not related to any existing directors and is not debarred from holding a directorship.
Key Highlights
- Shanti Ekambaram appointed as Additional Independent Director.
- Appointment effective July 30, 2026, for a 3-year term.
- Ms. Ekambaram has 39 years of financial services experience.
- She is not related to any current company directors.
- Appointment is subject to shareholder approval.
Price Impact
More from TORNTPHARM